Causes of death of HIV-infected patients in the highly active antiretroviral therapy era

被引:0
|
作者
Roca, B [1 ]
Rovira, RE [1 ]
Perez, AP [1 ]
Cabestany, B [1 ]
机构
[1] Gen Hosp, Castellon, Spain
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
124
引用
收藏
页码:L82 / L82
页数:1
相关论文
共 50 条
  • [21] Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy
    Werneck-Silva, Ana Luiza
    Prado, Ivete Bedin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (01) : 135 - 139
  • [22] A Study of Cytomegalovirus Serology among HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era
    Sufiawati, Irna
    Widyaputra, Sunardhi
    Djajakusumah, Tony S.
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2013, 45 (02): : 112 - 117
  • [23] Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy
    Dickson, S. J.
    Batson, S.
    Copas, A. J.
    Edwards, S. G.
    Singer, M.
    Miller, R. F.
    THORAX, 2007, 62 (11) : 964 - 968
  • [24] Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
    Kirk, O
    Pedersen, C
    Cozzi-Lepri, A
    Antunes, F
    Miller, V
    Gatell, JM
    Katlama, C
    Lazzarin, A
    Skinhoj, P
    Barton, SE
    BLOOD, 2001, 98 (12) : 3406 - 3412
  • [25] Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
    Isaline Coquet
    Juliette Pavie
    Pierre Palmer
    François Barbier
    Stéphane Legriel
    Julien Mayaux
    Michel Jean Molina
    Benoît Schlemmer
    Elie Azoulay
    Critical Care, 14
  • [26] Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
    Coquet, Isaline
    Pavie, Juliette
    Palmer, Pierre
    Barbier, Francois
    Legriel, Stephane
    Mayaux, Julien
    Molina, Jean Michel
    Schlemmer, Benoit
    Azoulay, Elie
    CRITICAL CARE, 2010, 14 (03):
  • [27] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
    Bernasconi, E
    Uhr, M
    Magenta, L
    Ranno, A
    Telenti, A
    AIDS, 2001, 15 (08) : 1081 - 1082
  • [28] Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Sendi, PP
    Bucher, HC
    Harr, T
    Craig, BA
    Schwietert, M
    Pfluger, D
    Gafni, A
    Battegay, M
    AIDS, 1999, 13 (09) : 1115 - 1122
  • [29] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
    Jericó, C
    Knobel, H
    Carmona, A
    Sorli, ML
    López-Colomés, JL
    Pedro-Botet, J
    MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
  • [30] Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients
    Barbaro, G
    Klatt, EC
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (18) : 1475 - 1481